17-72411715-C-T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000457958.7(LINC00511):​n.137-6899G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.391 in 151,966 control chromosomes in the GnomAD database, including 12,477 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.39 ( 12477 hom., cov: 32)

Consequence

LINC00511
ENST00000457958.7 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.823

Publications

8 publications found
Variant links:
Genes affected
LINC00511 (HGNC:43564): (long intergenic non-protein coding RNA 511)
LINC00673 (HGNC:44354): (long intergenic non-protein coding RNA 673) This gene produces a long non-protein coding RNA that is involved in the regulation of gene expression during tumor progression. This transcript can promote cell proliferation in gastric cancer through interaction with enhancer of zeste 2 and other epigenetic suppressors of gene expression, thereby downregulating target genes including Kruppel like factors 2 and 4. This transcript may also act as a tumor suppressor by promoting interaction between protein tyrosine phosphatase, non-receptor type 11 (Ptpn11) and ubiquitin ligase, resulting in degradation of Ptpn11 and lowered oncogenic signalling. Naturally-occurring variation at this locus results in the formation of a binding site for miR-1231, which negatively regulates activity of this transcript. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2017]

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript ENST00000457958.7, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.793 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000457958.7. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
LINC00673
NR_036488.1
n.763-6899G>A
intron
N/A
LINC00673
NR_137280.2
n.931-6899G>A
intron
N/A
LINC00673
NR_137281.2
n.1028-6899G>A
intron
N/A

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
LINC00511
ENST00000457958.7
TSL:1
n.137-6899G>A
intron
N/A
LINC00511
ENST00000453722.6
TSL:2
n.763-10294G>A
intron
N/A
LINC00511
ENST00000577828.6
TSL:3
n.398-6899G>A
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.391
AC:
59433
AN:
151848
Hom.:
12483
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.442
Gnomad AMI
AF:
0.212
Gnomad AMR
AF:
0.305
Gnomad ASJ
AF:
0.335
Gnomad EAS
AF:
0.814
Gnomad SAS
AF:
0.430
Gnomad FIN
AF:
0.440
Gnomad MID
AF:
0.386
Gnomad NFE
AF:
0.343
Gnomad OTH
AF:
0.390
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.391
AC:
59442
AN:
151966
Hom.:
12477
Cov.:
32
AF XY:
0.396
AC XY:
29421
AN XY:
74268
show subpopulations
African (AFR)
AF:
0.441
AC:
18274
AN:
41430
American (AMR)
AF:
0.305
AC:
4659
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.335
AC:
1161
AN:
3468
East Asian (EAS)
AF:
0.813
AC:
4203
AN:
5168
South Asian (SAS)
AF:
0.429
AC:
2064
AN:
4806
European-Finnish (FIN)
AF:
0.440
AC:
4637
AN:
10548
Middle Eastern (MID)
AF:
0.384
AC:
113
AN:
294
European-Non Finnish (NFE)
AF:
0.343
AC:
23317
AN:
67936
Other (OTH)
AF:
0.389
AC:
821
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1792
3584
5377
7169
8961
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
572
1144
1716
2288
2860
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.368
Hom.:
30742
Bravo
AF:
0.390
Asia WGS
AF:
0.561
AC:
1948
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.88
CADD
Benign
0.27
DANN
Benign
0.67
PhyloP100
-0.82

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs3744311;
hg19: chr17-70407856;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.